nodes	percent_of_prediction	percent_of_DWPC	metapath
Adapalene—RXRG—Regulation of Androgen receptor activity—SPDEF—colon cancer	0.0461	0.0599	CbGpPWpGaD
Adapalene—RXRB—Regulation of Androgen receptor activity—SPDEF—colon cancer	0.0433	0.0563	CbGpPWpGaD
Adapalene—RXRA—Regulation of Androgen receptor activity—SPDEF—colon cancer	0.0226	0.0294	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptors—HNF4A—colon cancer	0.0169	0.0219	CbGpPWpGaD
Adapalene—RXRG—Nuclear Receptors—HNF4A—colon cancer	0.0154	0.0201	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptors—HNF4A—colon cancer	0.0151	0.0197	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptors—HNF4A—colon cancer	0.0145	0.0189	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptors—HNF4A—colon cancer	0.0145	0.0189	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.0133	0.0173	CbGpPWpGaD
Adapalene—Keratoconjunctivitis—Capecitabine—colon cancer	0.0131	0.0993	CcSEcCtD
Adapalene—RXRG—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.0122	0.0159	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.012	0.0155	CbGpPWpGaD
Adapalene—RXRA—renal system—colon cancer	0.0118	0.12	CbGeAlD
Adapalene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.0115	0.015	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.0115	0.0149	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.0115	0.0149	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.0103	0.0134	CbGpPWpGaD
Adapalene—Oral herpes—Capecitabine—colon cancer	0.0102	0.077	CcSEcCtD
Adapalene—RARG—RXR and RAR heterodimerization with other nuclear receptor—PPARG—colon cancer	0.00992	0.0129	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.0099	0.0129	CbGpPWpGaD
Adapalene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—PPARG—colon cancer	0.00908	0.0118	CbGpPWpGaD
Adapalene—RARB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—colon cancer	0.0089	0.0116	CbGpPWpGaD
Adapalene—RARA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—colon cancer	0.00853	0.0111	CbGpPWpGaD
Adapalene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—PPARG—colon cancer	0.00853	0.0111	CbGpPWpGaD
Adapalene—RARA—renal system—colon cancer	0.00814	0.0827	CbGeAlD
Adapalene—RARG—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.00801	0.0104	CbGpPWpGaD
Adapalene—Skin irritation—Fluorouracil—colon cancer	0.00793	0.06	CcSEcCtD
Adapalene—Application site pain—Fluorouracil—colon cancer	0.0078	0.059	CcSEcCtD
Adapalene—RARB—vagina—colon cancer	0.00769	0.0781	CbGeAlD
Adapalene—RXRA—Nuclear Receptors—HNF4A—colon cancer	0.00756	0.00983	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptors—PPARG—colon cancer	0.00732	0.00952	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.00724	0.00941	CbGpPWpGaD
Adapalene—RXRA—liver—colon cancer	0.00722	0.0733	CbGeAlD
Adapalene—RARB—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.00718	0.00934	CbGpPWpGaD
Adapalene—RARG—digestive system—colon cancer	0.0071	0.0721	CbGeAlD
Adapalene—RXRB—vagina—colon cancer	0.00707	0.0717	CbGeAlD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.00694	0.00902	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	0.00689	0.00895	CbGpPWpGaD
Adapalene—RARA—lymphoid tissue—colon cancer	0.00676	0.0686	CbGeAlD
Adapalene—RXRG—Nuclear Receptors—PPARG—colon cancer	0.0067	0.00871	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptors—PPARG—colon cancer	0.00657	0.00854	CbGpPWpGaD
Adapalene—RARB—liver—colon cancer	0.00649	0.0659	CbGeAlD
Adapalene—RXRB—Nuclear Receptors—PPARG—colon cancer	0.0063	0.00819	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptors—PPARG—colon cancer	0.0063	0.00819	CbGpPWpGaD
Adapalene—RARG—vagina—colon cancer	0.00627	0.0637	CbGeAlD
Adapalene—RARA—bone marrow—colon cancer	0.00616	0.0625	CbGeAlD
Adapalene—RXRA—Nuclear Receptor transcription pathway—HNF4A—colon cancer	0.00597	0.00777	CbGpPWpGaD
Adapalene—RXRB—liver—colon cancer	0.00596	0.0605	CbGeAlD
Adapalene—Sunburn—Methotrexate—colon cancer	0.00591	0.0447	CcSEcCtD
Adapalene—RARG—Retinoic acid receptors-mediated signaling—EP300—colon cancer	0.00579	0.00753	CbGpPWpGaD
Adapalene—RARG—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00579	0.00752	CbGpPWpGaD
Adapalene—RARG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—colon cancer	0.00564	0.00734	CbGpPWpGaD
Adapalene—RXRG—a6b1 and a6b4 Integrin signaling—CDH1—colon cancer	0.00558	0.00725	CbGpPWpGaD
Adapalene—RXRA—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.00541	0.00704	CbGpPWpGaD
Adapalene—RXRG—Retinoic acid receptors-mediated signaling—EP300—colon cancer	0.0053	0.00688	CbGpPWpGaD
Adapalene—RXRG—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00529	0.00688	CbGpPWpGaD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—CDH1—colon cancer	0.00525	0.00682	CbGpPWpGaD
Adapalene—RARB—Retinoic acid receptors-mediated signaling—EP300—colon cancer	0.00519	0.00675	CbGpPWpGaD
Adapalene—RARB—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00519	0.00675	CbGpPWpGaD
Adapalene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—colon cancer	0.00516	0.00671	CbGpPWpGaD
Adapalene—RXRA—Transcription factor regulation in adipogenesis—PPARG—colon cancer	0.00508	0.00661	CbGpPWpGaD
Adapalene—RARB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—colon cancer	0.00506	0.00658	CbGpPWpGaD
Adapalene—RXRB—Retinoic acid receptors-mediated signaling—EP300—colon cancer	0.00498	0.00647	CbGpPWpGaD
Adapalene—RARA—Retinoic acid receptors-mediated signaling—EP300—colon cancer	0.00498	0.00647	CbGpPWpGaD
Adapalene—RXRB—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00498	0.00647	CbGpPWpGaD
Adapalene—RARA—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00498	0.00647	CbGpPWpGaD
Adapalene—RARA—liver—colon cancer	0.00498	0.0505	CbGeAlD
Adapalene—RARB—lymph node—colon cancer	0.00497	0.0505	CbGeAlD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.00494	0.00642	CbGpPWpGaD
Adapalene—RARA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—colon cancer	0.00485	0.00631	CbGpPWpGaD
Adapalene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—colon cancer	0.00485	0.00631	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.00474	0.00616	CbGpPWpGaD
Adapalene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—PPARG—colon cancer	0.00445	0.00578	CbGpPWpGaD
Adapalene—Stinging—Fluorouracil—colon cancer	0.00424	0.032	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.00416	0.00541	CbGpPWpGaD
Adapalene—RARG—lymph node—colon cancer	0.00406	0.0412	CbGeAlD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.00399	0.00518	CbGpPWpGaD
Adapalene—RARA—lymph node—colon cancer	0.00382	0.0387	CbGeAlD
Adapalene—Herpes simplex—Fluorouracil—colon cancer	0.00372	0.0282	CcSEcCtD
Adapalene—Keratitis—Capecitabine—colon cancer	0.0037	0.028	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TOP1—colon cancer	0.00362	0.0047	CbGpPWpGaD
Adapalene—RARG—Retinoic acid receptors-mediated signaling—AKT1—colon cancer	0.0035	0.00455	CbGpPWpGaD
Adapalene—Dermatitis contact—Fluorouracil—colon cancer	0.00339	0.0256	CcSEcCtD
Adapalene—RXRG—Regulation of Androgen receptor activity—EP300—colon cancer	0.00336	0.00437	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.00332	0.00432	CbGpPWpGaD
Adapalene—RXRA—Nuclear Receptors—PPARG—colon cancer	0.00328	0.00427	CbGpPWpGaD
Adapalene—RXRG—Regulation of Androgen receptor activity—SRC—colon cancer	0.00327	0.00425	CbGpPWpGaD
Adapalene—RXRG—a6b1 and a6b4 Integrin signaling—EGFR—colon cancer	0.00326	0.00424	CbGpPWpGaD
Adapalene—RXRG—Retinoic acid receptors-mediated signaling—AKT1—colon cancer	0.0032	0.00416	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.00319	0.00414	CbGpPWpGaD
Adapalene—RXRA—PPAR Alpha Pathway—CCND1—colon cancer	0.00316	0.00411	CbGpPWpGaD
Adapalene—RXRB—Regulation of Androgen receptor activity—EP300—colon cancer	0.00316	0.00411	CbGpPWpGaD
Adapalene—RARB—Retinoic acid receptors-mediated signaling—AKT1—colon cancer	0.00314	0.00408	CbGpPWpGaD
Adapalene—RXRA—REV-ERBA represses gene expression—EP300—colon cancer	0.0031	0.00403	CbGpPWpGaD
Adapalene—RXRB—Regulation of Androgen receptor activity—SRC—colon cancer	0.00307	0.00399	CbGpPWpGaD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—EGFR—colon cancer	0.00307	0.00399	CbGpPWpGaD
Adapalene—RXRB—Retinoic acid receptors-mediated signaling—AKT1—colon cancer	0.00301	0.00391	CbGpPWpGaD
Adapalene—RARA—Retinoic acid receptors-mediated signaling—AKT1—colon cancer	0.00301	0.00391	CbGpPWpGaD
Adapalene—RXRA—RORA activates circadian gene expression—EP300—colon cancer	0.003	0.0039	CbGpPWpGaD
Adapalene—RXRG—a6b1 and a6b4 Integrin signaling—PIK3CA—colon cancer	0.00283	0.00368	CbGpPWpGaD
Adapalene—Dermatitis exfoliative—Irinotecan—colon cancer	0.00276	0.0208	CcSEcCtD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—CDH1—colon cancer	0.00273	0.00355	CbGpPWpGaD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—PIK3CA—colon cancer	0.00266	0.00346	CbGpPWpGaD
Adapalene—Skin discolouration—Capecitabine—colon cancer	0.00265	0.0201	CcSEcCtD
Adapalene—RXRG—a6b1 and a6b4 Integrin signaling—HRAS—colon cancer	0.00262	0.00341	CbGpPWpGaD
Adapalene—Dermatitis bullous—Fluorouracil—colon cancer	0.00261	0.0197	CcSEcCtD
Adapalene—Herpes simplex—Capecitabine—colon cancer	0.0026	0.0197	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.00259	0.00337	CbGpPWpGaD
Adapalene—RXRA—Retinoic acid receptors-mediated signaling—EP300—colon cancer	0.00259	0.00337	CbGpPWpGaD
Adapalene—RXRA—Nuclear Receptor transcription pathway—PPARG—colon cancer	0.00259	0.00337	CbGpPWpGaD
Adapalene—Burning sensation—Methotrexate—colon cancer	0.00257	0.0194	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.00255	0.00331	CbGpPWpGaD
Adapalene—RXRA—PPAR Alpha Pathway—MYC—colon cancer	0.00254	0.0033	CbGpPWpGaD
Adapalene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—colon cancer	0.00253	0.00329	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—PPARG—colon cancer	0.0025	0.00326	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.00249	0.00323	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—DCC—colon cancer	0.00247	0.00321	CbGpPWpGaD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—colon cancer	0.00246	0.0032	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.00245	0.00319	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.00244	0.00318	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—PPARG—colon cancer	0.00235	0.00306	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.00235	0.00306	CbGpPWpGaD
Adapalene—RXRG—a6b1 and a6b4 Integrin signaling—AKT1—colon cancer	0.00231	0.00301	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—HNF4A—colon cancer	0.0023	0.00299	CbGpPWpGaD
Adapalene—Skin exfoliation—Capecitabine—colon cancer	0.00229	0.0173	CcSEcCtD
Adapalene—Dry skin—Fluorouracil—colon cancer	0.00228	0.0173	CcSEcCtD
Adapalene—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—colon cancer	0.00219	0.00285	CbGpPWpGaD
Adapalene—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—colon cancer	0.00218	0.00283	CbGpPWpGaD
Adapalene—Photosensitivity reaction—Vincristine—colon cancer	0.00211	0.0159	CcSEcCtD
Adapalene—RXRG—Generic Transcription Pathway—HNF4A—colon cancer	0.00211	0.00274	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—HNF4A—colon cancer	0.00208	0.0027	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—HNF4A—colon cancer	0.00207	0.00269	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—HNF4A—colon cancer	0.00198	0.00257	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—HNF4A—colon cancer	0.00198	0.00257	CbGpPWpGaD
Adapalene—Skin discolouration—Methotrexate—colon cancer	0.00198	0.0149	CcSEcCtD
Adapalene—Photosensitivity reaction—Fluorouracil—colon cancer	0.00197	0.0149	CcSEcCtD
Adapalene—Herpes simplex—Methotrexate—colon cancer	0.00194	0.0146	CcSEcCtD
Adapalene—Eye pain—Capecitabine—colon cancer	0.00193	0.0146	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.00187	0.00243	CbGpPWpGaD
Adapalene—Conjunctivitis—Fluorouracil—colon cancer	0.00187	0.0141	CcSEcCtD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—PPARG—colon cancer	0.00187	0.00243	CbGpPWpGaD
Adapalene—Dermatitis exfoliative—Capecitabine—colon cancer	0.00184	0.0139	CcSEcCtD
Adapalene—Dermatitis bullous—Capecitabine—colon cancer	0.00182	0.0138	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.00179	0.00233	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—CTNNB1—colon cancer	0.00176	0.00229	CbGpPWpGaD
Adapalene—RXRG—Adipogenesis—CDKN1A—colon cancer	0.00172	0.00224	CbGpPWpGaD
Adapalene—Skin exfoliation—Methotrexate—colon cancer	0.0017	0.0129	CcSEcCtD
Adapalene—Face oedema—Capecitabine—colon cancer	0.00168	0.0127	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	0.00166	0.00216	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—CTNNB1—colon cancer	0.00166	0.00215	CbGpPWpGaD
Adapalene—RXRA—Regulation of Androgen receptor activity—EP300—colon cancer	0.00165	0.00214	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—CDKN1A—colon cancer	0.00162	0.0021	CbGpPWpGaD
Adapalene—RXRA—Regulation of Androgen receptor activity—SRC—colon cancer	0.0016	0.00208	CbGpPWpGaD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—EGFR—colon cancer	0.0016	0.00208	CbGpPWpGaD
Adapalene—RXRA—Circadian Clock—EP300—colon cancer	0.0016	0.00208	CbGpPWpGaD
Adapalene—Dry skin—Capecitabine—colon cancer	0.0016	0.0121	CcSEcCtD
Adapalene—RXRA—Retinoic acid receptors-mediated signaling—AKT1—colon cancer	0.00157	0.00204	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CA7—colon cancer	0.00151	0.00196	CbGpPWpGaD
Adapalene—Erythema—Fluorouracil—colon cancer	0.0015	0.0113	CcSEcCtD
Adapalene—RXRG—Adipogenesis—TGFB1—colon cancer	0.00142	0.00185	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.00142	0.00185	CbGpPWpGaD
Adapalene—RXRA—PPARA activates gene expression—PPARG—colon cancer	0.0014	0.00182	CbGpPWpGaD
Adapalene—Convulsion—Vincristine—colon cancer	0.00139	0.0105	CcSEcCtD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—PIK3CA—colon cancer	0.00139	0.0018	CbGpPWpGaD
Adapalene—Dermatitis exfoliative—Methotrexate—colon cancer	0.00137	0.0104	CcSEcCtD
Adapalene—Photosensitivity reaction—Capecitabine—colon cancer	0.00137	0.0104	CcSEcCtD
Adapalene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—colon cancer	0.00137	0.00178	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.00136	0.00177	CbGpPWpGaD
Adapalene—RARA—Adipogenesis—TGFB1—colon cancer	0.00134	0.00174	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.00132	0.00171	CbGpPWpGaD
Adapalene—Conjunctivitis—Capecitabine—colon cancer	0.0013	0.00986	CcSEcCtD
Adapalene—Convulsion—Fluorouracil—colon cancer	0.0013	0.00983	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—ABCB1—colon cancer	0.0013	0.00169	CbGpPWpGaD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—colon cancer	0.00128	0.00167	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.00128	0.00167	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	0.00127	0.00166	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.00127	0.00165	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.00126	0.00164	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.00124	0.00161	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.00123	0.0016	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—PPARG—colon cancer	0.00123	0.0016	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	0.00123	0.00159	CbGpPWpGaD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—EP300—colon cancer	0.00122	0.00159	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.00122	0.00158	CbGpPWpGaD
Adapalene—Hepatitis—Capecitabine—colon cancer	0.0012	0.00911	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.00119	0.00155	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.00118	0.00154	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—DCC—colon cancer	0.00115	0.0015	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.00115	0.00149	CbGpPWpGaD
Adapalene—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—colon cancer	0.00113	0.00147	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.00113	0.00147	CbGpPWpGaD
Adapalene—Pain—Vincristine—colon cancer	0.00112	0.00849	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.00112	0.00145	CbGpPWpGaD
Adapalene—RARG—Gene Expression—HNF4A—colon cancer	0.00111	0.00144	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.0011	0.00143	CbGpPWpGaD
Adapalene—Pain—Irinotecan—colon cancer	0.00109	0.00827	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.00107	0.00139	CbGpPWpGaD
Adapalene—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—colon cancer	0.00106	0.00138	CbGpPWpGaD
Adapalene—Erythema—Capecitabine—colon cancer	0.00105	0.00793	CcSEcCtD
Adapalene—Pain—Fluorouracil—colon cancer	0.00105	0.00792	CcSEcCtD
Adapalene—RXRA—Generic Transcription Pathway—HNF4A—colon cancer	0.00103	0.00134	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.00103	0.00134	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.00103	0.00133	CbGpPWpGaD
Adapalene—Photosensitivity reaction—Methotrexate—colon cancer	0.00102	0.00773	CcSEcCtD
Adapalene—RXRG—Gene Expression—HNF4A—colon cancer	0.00101	0.00132	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.00101	0.00131	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—PPARG—colon cancer	0.001	0.0013	CbGpPWpGaD
Adapalene—RARB—Gene Expression—HNF4A—colon cancer	0.000994	0.00129	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000987	0.00128	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000984	0.00128	CbGpPWpGaD
Adapalene—Urticaria—Fluorouracil—colon cancer	0.000973	0.00735	CcSEcCtD
Adapalene—RXRA—Developmental Biology—HNF4A—colon cancer	0.000971	0.00126	CbGpPWpGaD
Adapalene—Conjunctivitis—Methotrexate—colon cancer	0.000971	0.00734	CcSEcCtD
Adapalene—Hypersensitivity—Vincristine—colon cancer	0.000967	0.00731	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000965	0.00125	CbGpPWpGaD
Adapalene—RARA—Gene Expression—HNF4A—colon cancer	0.000953	0.00124	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—HNF4A—colon cancer	0.000953	0.00124	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000951	0.00124	CbGpPWpGaD
Adapalene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—colon cancer	0.000946	0.00123	CbGpPWpGaD
Adapalene—Hypersensitivity—Irinotecan—colon cancer	0.000942	0.00712	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—APC—colon cancer	0.000935	0.00121	CbGpPWpGaD
Adapalene—RXRA—PPARA activates gene expression—EP300—colon cancer	0.000918	0.00119	CbGpPWpGaD
Adapalene—RXRG—Generic Transcription Pathway—PPARG—colon cancer	0.000914	0.00119	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ODC1—colon cancer	0.000912	0.00119	CbGpPWpGaD
Adapalene—RXRA—Metabolism—CHST5—colon cancer	0.000912	0.00119	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000912	0.00119	CbGpPWpGaD
Adapalene—Hypersensitivity—Fluorouracil—colon cancer	0.000902	0.00682	CcSEcCtD
Adapalene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—colon cancer	0.000898	0.00117	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—PPARG—colon cancer	0.000897	0.00117	CbGpPWpGaD
Adapalene—Hepatitis—Methotrexate—colon cancer	0.000896	0.00678	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000874	0.00114	CbGpPWpGaD
Adapalene—Pruritus—Fluorouracil—colon cancer	0.000866	0.00655	CcSEcCtD
Adapalene—RXRA—Adipogenesis—CTNNB1—colon cancer	0.000864	0.00112	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—PPARG—colon cancer	0.00086	0.00112	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—PPARG—colon cancer	0.00086	0.00112	CbGpPWpGaD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000845	0.0011	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—CDKN1A—colon cancer	0.000844	0.0011	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000838	0.00109	CbGpPWpGaD
Adapalene—Rash—Vincristine—colon cancer	0.000828	0.00626	CcSEcCtD
Adapalene—Dermatitis—Vincristine—colon cancer	0.000827	0.00625	CcSEcCtD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.00081	0.00105	CbGpPWpGaD
Adapalene—Rash—Irinotecan—colon cancer	0.000806	0.00609	CcSEcCtD
Adapalene—Dermatitis—Irinotecan—colon cancer	0.000805	0.00609	CcSEcCtD
Adapalene—Erythema—Methotrexate—colon cancer	0.00078	0.0059	CcSEcCtD
Adapalene—Rash—Fluorouracil—colon cancer	0.000772	0.00584	CcSEcCtD
Adapalene—Dermatitis—Fluorouracil—colon cancer	0.000771	0.00583	CcSEcCtD
Adapalene—Pain—Capecitabine—colon cancer	0.000732	0.00553	CcSEcCtD
Adapalene—RARB—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000714	0.000928	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	0.00071	0.000922	CbGpPWpGaD
Adapalene—RXRA—Adipogenesis—TGFB1—colon cancer	0.000698	0.000907	CbGpPWpGaD
Adapalene—RARA—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000684	0.00089	CbGpPWpGaD
Adapalene—Urticaria—Capecitabine—colon cancer	0.00068	0.00514	CcSEcCtD
Adapalene—Convulsion—Methotrexate—colon cancer	0.000676	0.00511	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	0.000659	0.000856	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	0.000641	0.000833	CbGpPWpGaD
Adapalene—RXRA—NRF2 pathway—TGFB1—colon cancer	0.000636	0.000827	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	0.000635	0.000825	CbGpPWpGaD
Adapalene—Hypersensitivity—Capecitabine—colon cancer	0.00063	0.00477	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	0.00062	0.000806	CbGpPWpGaD
Adapalene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—colon cancer	0.000619	0.000804	CbGpPWpGaD
Adapalene—Pruritus—Capecitabine—colon cancer	0.000605	0.00458	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	0.00059	0.000767	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	0.000574	0.000746	CbGpPWpGaD
Adapalene—RARG—Generic Transcription Pathway—MYC—colon cancer	0.00057	0.000741	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	0.000559	0.000727	CbGpPWpGaD
Adapalene—Pain—Methotrexate—colon cancer	0.000545	0.00412	CcSEcCtD
Adapalene—Rash—Capecitabine—colon cancer	0.000539	0.00408	CcSEcCtD
Adapalene—Dermatitis—Capecitabine—colon cancer	0.000539	0.00408	CcSEcCtD
Adapalene—RXRG—Generic Transcription Pathway—MYC—colon cancer	0.000521	0.000678	CbGpPWpGaD
Adapalene—RXRA—Transmembrane transport of small molecules—ABCB1—colon cancer	0.000515	0.000669	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	0.000514	0.000669	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	0.000513	0.000667	CbGpPWpGaD
Adapalene—RARB—Generic Transcription Pathway—MYC—colon cancer	0.000511	0.000665	CbGpPWpGaD
Adapalene—Urticaria—Methotrexate—colon cancer	0.000506	0.00383	CcSEcCtD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	0.000503	0.000654	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—HNF4A—colon cancer	0.000497	0.000646	CbGpPWpGaD
Adapalene—RXRB—Generic Transcription Pathway—MYC—colon cancer	0.00049	0.000637	CbGpPWpGaD
Adapalene—RARA—Generic Transcription Pathway—MYC—colon cancer	0.00049	0.000637	CbGpPWpGaD
Adapalene—RARG—Gene Expression—PPARG—colon cancer	0.000481	0.000626	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	0.000475	0.000618	CbGpPWpGaD
Adapalene—Hypersensitivity—Methotrexate—colon cancer	0.000469	0.00355	CcSEcCtD
Adapalene—Pruritus—Methotrexate—colon cancer	0.000451	0.00341	CcSEcCtD
Adapalene—RXRA—Generic Transcription Pathway—PPARG—colon cancer	0.000448	0.000583	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—PPARG—colon cancer	0.00044	0.000572	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	0.000437	0.000568	CbGpPWpGaD
Adapalene—RARB—Gene Expression—PPARG—colon cancer	0.000432	0.000561	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	0.000422	0.000549	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—PPARG—colon cancer	0.000422	0.000548	CbGpPWpGaD
Adapalene—RARA—Gene Expression—PPARG—colon cancer	0.000414	0.000538	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—PPARG—colon cancer	0.000414	0.000538	CbGpPWpGaD
Adapalene—Rash—Methotrexate—colon cancer	0.000402	0.00304	CcSEcCtD
Adapalene—Dermatitis—Methotrexate—colon cancer	0.000401	0.00303	CcSEcCtD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PPARG—colon cancer	0.000377	0.00049	CbGpPWpGaD
Adapalene—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	0.000357	0.000464	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—CTNNB1—colon cancer	0.000297	0.000386	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	0.000296	0.000385	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—EP300—colon cancer	0.000276	0.000359	CbGpPWpGaD
Adapalene—RARG—Gene Expression—MYC—colon cancer	0.000274	0.000357	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—SRC—colon cancer	0.000268	0.000349	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—VEGFA—colon cancer	0.000261	0.00034	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—NRAS—colon cancer	0.000258	0.000336	CbGpPWpGaD
Adapalene—RXRA—Generic Transcription Pathway—MYC—colon cancer	0.000255	0.000332	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—MYC—colon cancer	0.000251	0.000326	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—EP300—colon cancer	0.000246	0.00032	CbGpPWpGaD
Adapalene—RARB—Gene Expression—MYC—colon cancer	0.000246	0.00032	CbGpPWpGaD
Adapalene—RXRA—Metabolism—ABCB1—colon cancer	0.000241	0.000313	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—TGFB1—colon cancer	0.00024	0.000312	CbGpPWpGaD
Adapalene—RXRA—Metabolism—TYMS—colon cancer	0.000237	0.000308	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—MYC—colon cancer	0.000236	0.000307	CbGpPWpGaD
Adapalene—RARA—Gene Expression—MYC—colon cancer	0.000236	0.000307	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—EGFR—colon cancer	0.000235	0.000306	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—KRAS—colon cancer	0.000222	0.000289	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—PPARG—colon cancer	0.000216	0.00028	CbGpPWpGaD
Adapalene—RARG—Gene Expression—AKT1—colon cancer	0.00019	0.000247	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—HRAS—colon cancer	0.000189	0.000246	CbGpPWpGaD
Adapalene—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	0.000182	0.000237	CbGpPWpGaD
Adapalene—RXRG—Gene Expression—AKT1—colon cancer	0.000174	0.000226	CbGpPWpGaD
Adapalene—RARB—Gene Expression—AKT1—colon cancer	0.000171	0.000222	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PPARG—colon cancer	0.000168	0.000218	CbGpPWpGaD
Adapalene—RXRA—Developmental Biology—AKT1—colon cancer	0.000167	0.000217	CbGpPWpGaD
Adapalene—RARA—Gene Expression—AKT1—colon cancer	0.000164	0.000213	CbGpPWpGaD
Adapalene—RXRB—Gene Expression—AKT1—colon cancer	0.000164	0.000213	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PTGS2—colon cancer	0.000132	0.000172	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—MYC—colon cancer	0.000123	0.00016	CbGpPWpGaD
Adapalene—RXRA—Metabolism—EP300—colon cancer	0.00011	0.000143	CbGpPWpGaD
Adapalene—RXRA—Gene Expression—AKT1—colon cancer	8.53e-05	0.000111	CbGpPWpGaD
Adapalene—RXRA—Metabolism—PIK3CA—colon cancer	8.12e-05	0.000106	CbGpPWpGaD
Adapalene—RXRA—Metabolism—AKT1—colon cancer	6.63e-05	8.62e-05	CbGpPWpGaD
